Perioperative Database of Chinese Elderly Patients
Launched by CHINESE PLA GENERAL HOSPITAL · Jun 2, 2021
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding the health challenges elderly patients face during and after surgery. Researchers want to create a database that collects information about complications that may affect various body systems, like the brain, heart, kidneys, and lungs, as well as issues like infections and pain. By gathering this information, they hope to identify how often these complications happen and what might increase the risk for older patients. They also aim to develop tools that can help predict and prevent these problems in the future.
To participate in this study, individuals must be at least 65 years old and scheduled for a surgery that requires an overnight hospital stay. However, those with severe cognitive impairments, significant communication difficulties, or certain types of surgeries (like heart or brain surgery) will not be eligible. Participants can expect to contribute valuable information that could improve the safety and care of elderly surgical patients. Overall, this trial is important for helping healthcare providers better understand and support older adults during their surgical journeys.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Geriatric surgical patients ≥65 years old, undergoing elective surgery with a planned overnight hospital stay following surgery.
- Exclusion Criteria:
- • Patients fully refused to participate in the study;
- • Patients with severe dementia, language disorder, severe hearing or visual impairment, coma, and end-stage status were excluded;
- • Patients whose surgeries were canceled;
- • Patients accepted cardiac surgeries were excluded from the heart injury section;
- • Patients accepted cardiac, neurosurgeries or were excluded from postoperative central nervous system and pain observation section;
- • Patients refused to participate in neurocognitive, anxiety, depression, or pain questionnaire were excluded from relative assessment and measurement.
About Chinese Pla General Hospital
The Chinese PLA General Hospital, a prominent military medical institution in Beijing, serves as a leading sponsor for clinical trials, focusing on advancing healthcare through innovative research and development. Renowned for its comprehensive medical services and cutting-edge research capabilities, the hospital is committed to improving patient outcomes through rigorous scientific investigation and collaboration with various stakeholders in the healthcare sector. With a multidisciplinary approach and a strong emphasis on evidence-based practices, the Chinese PLA General Hospital aims to contribute significantly to the global medical community by facilitating the development of safe and effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Trial Officials
Weidong Mi, PhD
Study Chair
Chinese PLA General Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials